Fertility and Sterility
Volume 90, Issue 6 , Pages 2091-2098, December 2008

Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing

  • Valerie L. Baker, M.D.

      Affiliations

    • Fertility Physicians of Northern California, San Jose, California
    • Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Stanford University Medical Center, Stanford, California
    • Corresponding Author InformationReprint requests: Valerie L. Baker, M.D., Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Stanford University Medical Center, 300 Pasteur Drive, Room HH333, Stanford, California 94305 (FAX: 650-736-7036).
  • ,
  • Heather M. Rone, B.S.

      Affiliations

    • Fertility Physicians of Northern California, San Jose, California
  • ,
  • Geoffrey David Adamson, M.D.

      Affiliations

    • Fertility Physicians of Northern California, San Jose, California

Received 6 April 2007; received in revised form 30 October 2007; accepted 30 October 2007. published online 13 February 2008.

Objective

To report preferences of recipient couples for genetic testing of their oocyte donors.

Design

Observational report of results from a genetic testing–options form implemented as part of routine care.

Setting

Private practice.

Patient(s)

Recipients and oocyte donors.

Intervention(s)

Recipient couples completed a form before screening of their oocyte donor that outlined required screening and recommended tests that the couple could accept or decline. Couples were given information about carrier frequency, risk to their child if results were abnormal, and cost.

Main Outcome Measure(s)

Percentage of couples accepting optional testing.

Result(s)

Of the 63 couples with data available from their first testing-options form, 42 (67%) accepted and 21 (33%) declined fragile X testing, whereas 34 (54%) accepted and 29 (46%) declined karyotyping. When asked whether they would accept additional testing of their donor if it was recommended by a genetic counselor, 15 (24%) said that they would accept additional testing regardless of cost, 35 (56%) declined, and 13 (20%) indicated that their decision would depend on the cost. In many cases, history was elicited by the genetic counselor or test results were obtained that influenced further testing, decisions to proceed, or provided information important for the child.

Conclusion(s)

Recipient couples sometimes chose to decline tests that we recommended but did not require, despite the relatively low cost of this testing compared with the total cost of the oocyte donation cycle.

Key Words: Oocyte donation, genetic testing, patient preferences

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 V.L.B. has received research support from Institute Biochimique (IBSA), Switzerland. H.M.R. is an employee of Fertility Physicians of Northern California. G.D.A. is CEO and a shareholder of Advanced Reproductive Care, Palo Alto, CA, and his spouse is a shareholder of Advanced Reproductive Care. G.D.A. is a physician and an owner of Fertility Physicians of Northern California, has received research support from IBSA, has been a speaker for Ferring Pharmaceuticals, Suffern, NY, and is on the LabCorp Advisory Board, Morrisville, NC.

PII: S0015-0282(07)03955-6

doi:10.1016/j.fertnstert.2007.10.069

Fertility and Sterility
Volume 90, Issue 6 , Pages 2091-2098, December 2008